High-quality, non-contrast MRA for Peripheral Artery Disease (PAD) imagingClinical confidence in peripheral runoff imaging with QISS

The incidence of peripheral artery disease (PAD) increased by approximately 13% in high-income countries over the last decade¹. The costs of PAD—to the patient, to healthcare delivery organizations, and to society—are significant². For example, the 10-year risk of death for PAD patients is 40%. They also have a three-times higher risk of all-cause death and a six-times higher risk of cardiovascular-related death than their peers without PAD³.

An accurate diagnosis of PAD is essential to combat the disease and ultimately stop or stall its progression—and, as a result, potentially avoid readmissions and improve patient outcomes. Doing so requires care providers to overcome three main challenges of effectively diagnosing PAD patients:

• Obtaining accurate and reproducible images.
• Minimizing risk and improving patient safety.
• Optimizing departmental resources for maximum efficiency.

Learn how QISS can help expand your MRA services—particularly for a growing diabetic population—by delivering non-contrast-enhanced images without compromising on quality or patient safety.